This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Johns Hopkins University. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: David M Berman: Innovator in Cancer Treatment
Introduction
David M Berman is a notable inventor based in Towson, MD (US). He has made significant contributions to the field of cancer treatment, particularly in the development of methods targeting bladder cancer. His innovative approach focuses on utilizing specific compounds to combat cancer stem cells.
Latest Patents
David M Berman holds a patent titled "Urothelial differentiation of urothelial carcinoma: a bladder cancer stem cell model." This invention provides a method for treating cancer in patients by administering a therapeutically effective regimen. The regimen includes a compound that targets the 67 laminin receptor (67LR). In particular, the patent outlines the use of antibodies or antibody fragments that bind to 67LR, as well as antibody conjugates linked to therapeutic agents. The invention also includes pharmaceutical compositions aimed at reducing cancer stem cells and methods for detecting and monitoring these cells based on their expression of 67LR.
Career Highlights
David M Berman is affiliated with Johns Hopkins University, where he continues to advance research in cancer treatment. His work has garnered attention for its potential to improve therapeutic outcomes for patients suffering from bladder cancer.
Collaborations
Some of his notable coworkers include William Matsui and Xiaobing He, who have collaborated with him on various research initiatives.
Conclusion
David M Berman's innovative work in cancer treatment exemplifies the impact of targeted therapies in modern medicine. His contributions are paving the way for more effective treatments for patients battling bladder cancer.